Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis

NCT03813199 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: ABX464 50mg
DRUG: Matching Placebo
DRUG: ABX464 100mg
DRUG: Methotrexate

Sponsor

Abivax S.A.